-transparent.png){kind=logo}
Desferrioxamine was given intravenously, at higher doses than previously reported, to counter the effects of transfusion-induced iron overload in four patients with beta thalassaemia major. In two of them retinal abnormalities developed, presenting with night blindness and field defects, which improved on withdrawal of the drug.
Related Publications
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
January 1987,
Nephron,
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
April 1985,
Lancet (London, England),
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
December 1990,
Lancet (London, England),
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
January 1992,
Haematologica,
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
May 1981,
Israel journal of medical sciences,
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
August 1983,
Lancet (London, England),
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
July 1985,
The Quarterly journal of medicine,
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
July 2012,
Indian journal of ophthalmology,
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
November 1982,
Archives of ophthalmology (Chicago, Ill. : 1960),
S C Davies, and
R E Marcus, and
J L Hungerford, and
M H Miller, and
G B Arden, and
E R Huehns
February 1983,
Cancer,
